Moffitt Cancer Center is a clinical research site located in Tampa, Florida, United States 33612.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Moffitt Cancer Center has participated in 971 clinical trials with 524 currently active.
Therapeutic areas: Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma.
Sponsors: H. Lee Moffitt Cancer Center and Research Institute, Regeneron Pharmaceuticals, MacroGenics.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Moffitt Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Moffitt Cancer Center has 971 clinical trials on record, with 524 currently active. Their work covers Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma.
Moffitt Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.